Australia's MedAdvisor surges on strong quarterly results

Adheris Health

23/04/2024 04:26

** Shares of MedAdvisor  MDR.AX  rise as much as 18.5% to
A$0.320, its biggest intraday pct gain since early-Jan
    ** Stock posts their highest level since March 4
    ** Medication technology co says Q3 gross profit up 48.5%,
operating revenue up 42.4%
    ** Says Q4 will result in solid growth YoY and contribute to
revenue growth and positive EBITDA for first time
    ** About 1.1 mln shares change hands, compared with the
30-day average volume of 281,093 shares
    ** Stock up 25.6% this year, as of last close

 (Reporting by Megha Rani in Bengaluru)
 ((Megha.Rani2@thomsonreuters.com;))